Retaglutide is a novel GLP-1 receptor agonist currently under research for the control of type 2 diabetes. This therapy works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://fayqibf607710.vidublog.com/37798522/semaglutide-a-potential-solution-for-diabetes